INAB
In8bioยทNASDAQ
--
--(--)
--
--(--)
INAB Profile
In8bio, Inc.
A clinical-stage biopharmaceutical company that focused on gamma-delta T cell product candidates for solid and liquid tumors
350 5th Avenue, Suite 5330 , New York, New York 10118
--
In8 bio, Inc., was incorporated in Bermuda on February 8, 2016. The Company is a leading clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapy candidates and gamma-delta T cell ligators for cancer and autoimmune diseases.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
